Dose Escalation Study of ADXS31-164 in Subjects With HER2 Expressing Solid Tumors
Clinical trial NCT02386501 · COMPLETED
Trial details
- NCT number
- NCT02386501
- Sponsor
- Advaxis, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2017-04-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.